Dexcom (DXCM) Inventory Average (2011 - 2026)

Dexcom (DXCM) has reported Inventory Average for 16 consecutive years, with $710.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 28.05% year-over-year to $710.0 million in Q2 2026; TTM through Jun 2026 was $710.0 million, a 28.05% increase from a year earlier, with the FY2025 full-year figure at $585.8 million, up 6.31% from the prior year.
• Inventory Average was $710.0 million for Q2 2026 at Dexcom, up from $661.4 million in the prior quarter.
• Over five years, Inventory Average peaked at $710.0 million in Q2 2026 and troughed at $308.8 million in Q4 2022.
• A 5-year average of $500.6 million and a median of $547.4 million in 2025 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average slipped 12.83% in 2022 and jumped 71.31% in 2023, its largest moves.
• Over 5 years, Inventory Average stood at $308.8 million in 2022, then jumped by 71.31% to $529.1 million in 2023, then gained by 6.68% to $564.4 million in 2024, then increased by 9.24% to $616.6 million in 2025, then grew by 15.15% to $710.0 million in 2026.
• The last three Inventory Average figures came in at $710.0 million (Q2 2026), $661.4 million (Q1 2026), and $616.6 million (Q4 2025), per Business Quant data.